We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.88B
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-12.09%
1 Year Est. Return
+32.38%
3 Year Est. Return
+99.93%
5 Year Est. Return
+115.9%
10 Year Est. Return
+395.31%
AUM
$782M
AUM Growth
-$99M
Cap. Flow
+$25.1M
Cap. Flow %
3.21%
Top 10 Hldgs %
15.26%
Holding
976
New
77
Increased
365
Reduced
320
Closed
139

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$3.22M
2
AMZN icon
Amazon
AMZN
+$2.38M
3
AAPL icon
Apple
AAPL
+$2.23M
4
CAG icon
Conagra Brands
CAG
+$2.07M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.75M

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.92%
2 Technology 11.65%
3 Healthcare 10.73%
4 Financials 9.86%
5 Consumer Discretionary 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNG icon
776
Scorpio Tankers
STNG
$4.11B
$48K 0.01%
2,743
-129
-4% -$2.4K
AUY
777
DELISTED
Yamana Gold, Inc.
AUY
$46K 0.01%
19,474
-2,606
-12% -$6.08K
APPS icon
778
Digital Turbine
APPS
$1.37B
$42K 0.01%
23,000
CDTX
779
DELISTED
Cidara Therapeutics
CDTX
$42K 0.01%
903
WFT
780
DELISTED
Weatherford International plc
WFT
$42K 0.01%
75,182
+335
+0.4% +$437
UWN
781
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
$40K 0.01%
17,000
-2,000
-11% -$4.82K
SRAX
782
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$38K ﹤0.01%
18,483
AFMD
783
DELISTED
Affimed
AFMD
$34K ﹤0.01%
1,100
LYG icon
784
Lloyds Banking Group
LYG
$86.8B
$32K ﹤0.01%
12,554
-14,912
-54% -$42.4K
RGLS
785
DELISTED
Regulus Therapeutics
RGLS
$30K ﹤0.01%
3,274
+1,973
+152% +$32.7K
NE
786
DELISTED
Noble Corporation
NE
$30K ﹤0.01%
11,567
+222
+2% +$1.05K
TRIB
787
Trinity Biotech
TRIB
$7.37M
$27K ﹤0.01%
79
-29
-27% -$13.4K
RAD
788
DELISTED
Rite Aid Corporation
RAD
$27K ﹤0.01%
1,894
+1,000
+112% +$21.1K
HOV icon
789
Hovnanian Enterprises
HOV
$705M
$26K ﹤0.01%
+1,520
New +$48.1K
PSV
790
DELISTED
Hermitage Offshore Services Ltd.
PSV
$25K ﹤0.01%
5,847
-1,071
-15% -$7.4K
NAT icon
791
Nordic American Tanker
NAT
$1.51B
$24K ﹤0.01%
+12,182
New +$31.7K
IRD
792
Opus Genetics
IRD
$361M
$24K ﹤0.01%
531
CRDF icon
793
Cardiff Oncology
CRDF
$85.6M
$21K ﹤0.01%
+6,767
New +$30.9K
AKAO
794
DELISTED
Achaogen Inc
AKAO
$20K ﹤0.01%
16,450
-56,300
-77% -$150K
NAVB
795
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$20K ﹤0.01%
9,700
MUX icon
796
McEwen Inc
MUX
$1.24B
$19K ﹤0.01%
1,020
LGCY
797
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$17K ﹤0.01%
+10,812
New +$34.6K
AVGR
798
DELISTED
Avinger, Inc. Common Stock
AVGR
$14K ﹤0.01%
+16
New +$26.6K
SLS icon
799
SELLAS Life Sciences
SLS
$2.82B
$12K ﹤0.01%
+202
New +$15.6K
NBSE
800
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$12K ﹤0.01%
338
+150
+80% +$10.9K

Similar funds

Wedbush Securities's Q4 2018 Portfolio in Review

As of Q4 2018, Wedbush Securities held 976 positions worth $782M, down 11% from $881M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Wedbush Securities deployed $25.1M of net new capital in Q4 2018, opening 77 new positions and adding to 365 existing holdings. Its largest new stake was Conagra Brands: 64,141 shares worth $1.37M.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Brookfield Property REIT Inc. Class A Common Stock, an estimated $6.66M trimmed.

  • Wedbush Securities's largest Q4 2018 buy was Conagra Brands: 64,141 shares worth $1.37M.
  • Wedbush Securities added most to Union Pacific in Q4 2018, an estimated $3.22M increase.
  • Wedbush Securities's biggest Q4 2018 reduction was Brookfield Property REIT Inc. Class A Common Stock, cutting an estimated $6.66M.
  • Wedbush Securities fully exited United States Natural Gas Fund in Q4 2018, selling an estimated $1M.
  • Wedbush Securities's ten largest holdings make up 15% of its $782M portfolio in Q4 2018.
  • Wedbush Securities opened 77 new positions and closed 139 in Q4 2018.
  • Wedbush Securities's portfolio value fell 11% quarter-over-quarter to $782M.

Based on Wedbush Securities's 13F filing for Q4 2018, filed 31 Jan 2019.